Skip to main content
. 2017 Jan 26;12(1):e0170924. doi: 10.1371/journal.pone.0170924

Fig 5. EE-AC inhibits the motility of B16-F0 cells.

Fig 5

B16-F0 cells were scratched and treated with 0.1% DMSO (negative control) or IC50 values of cisplatin (10 μM) or EE-AC (50 μg/mL). Inhibition of migration was observed using a phase contrast microscope (100 × magnification) at 0, 6, 12 and 18 h (Top panel), and the closure of the wound area was calculated (bottom panel). Values are significantly different by comparison with the cisplatin group. *p < 0.05; ***p < 0.001.